|
|
|
|
pmid:
|
Shalhoub V et al. |
Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors. |
1999 |
J. Cell. Biochem. |
pmid:10022507
|
Hsu H et al. |
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. |
1999 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:10097072
|
Nagai M and Sato N |
Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation. |
1999 |
Biochem. Biophys. Res. Commun. |
pmid:10208850
|
Burgess TL et al. |
The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. |
1999 |
J. Cell Biol. |
pmid:10225954
|
Kong YY et al. |
Osteoprotegerin ligand: a common link between osteoclastogenesis, lymph node formation and lymphocyte development. |
1999 |
Immunol. Cell Biol. |
pmid:10234557
|
Yano K et al. |
Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis. |
1999 |
J. Bone Miner. Res. |
pmid:10234572
|
Zhang XD et al. |
Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma. |
1999 |
Cancer Res. |
pmid:10364001
|
Spelsberg TC et al. |
The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. |
1999 |
Mol. Endocrinol. |
pmid:10379881
|
Yasuda H et al. |
A novel molecular mechanism modulating osteoclast differentiation and function. |
1999 |
Bone |
pmid:10423033
|
Roodman GD |
Cell biology of the osteoclast. |
1999 |
Exp. Hematol. |
pmid:10428500
|
Lee SK and Lorenzo JA |
Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. |
1999 |
Endocrinology |
pmid:10433211
|
Ito H et al. |
Hedgehog signaling molecules in bone marrow cells at the initial stage of fracture repair. |
1999 |
Biochem. Biophys. Res. Commun. |
pmid:10462495
|
Hofbauer LC et al. |
Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. |
1999 |
Endocrinology |
pmid:10465311
|
Morony S et al. |
A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3. |
1999 |
J. Bone Miner. Res. |
pmid:10469275
|
Sakata M et al. |
Expression of osteoprotegerin (osteoclastogenesis inhibitory factor) in cultures of human dental mesenchymal cells and epithelial cells. |
1999 |
J. Bone Miner. Res. |
pmid:10469276
|
Lazner F et al. |
Osteopetrosis and osteoporosis: two sides of the same coin. |
1999 |
Hum. Mol. Genet. |
pmid:10469835
|
Hofbauer LC |
Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolism. |
1999 |
Eur. J. Endocrinol. |
pmid:10474114
|
Wickelgren I |
Mining the genome for drugs. |
1999 |
Science |
pmid:10475849
|
Hofbauer LC et al. |
Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. |
1999 |
Endocrinology |
pmid:10499489
|
Thomas RJ et al. |
Breast cancer cells interact with osteoblasts to support osteoclast formation. |
1999 |
Endocrinology |
pmid:10499498
|
Itonaga I et al. |
1,25-Dihydroxyvitamin D(3) and prostaglandin E(2) act directly on circulating human osteoclast precursors. |
1999 |
Biochem. Biophys. Res. Commun. |
pmid:10529407
|
Nakagawa N et al. |
Basic fibroblast growth factor inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D(3) through suppressing the production of osteoclast differentiation factor. |
1999 |
Biochem. Biophys. Res. Commun. |
pmid:10548488
|
Nakagawa N et al. |
Basic fibroblast growth factor induces osteoclast formation by reciprocally regulating the production of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in mouse osteoblastic cells. |
1999 |
Biochem. Biophys. Res. Commun. |
pmid:10548507
|
Kong YY et al. |
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. |
1999 |
Nature |
pmid:10580503
|
Yamashita T et al. |
Retardation in bone resorption after bone marrow ablation in klotho mutant mice. |
2000 |
Endocrinology |
pmid:10614667
|
Itonaga I et al. |
Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages. |
2000 |
Ann. Rheum. Dis. |
pmid:10627423
|
Chikatsu N et al. |
Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro. |
2000 |
Biochem. Biophys. Res. Commun. |
pmid:10631114
|
Hofbauer LC et al. |
The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. |
2000 |
J. Bone Miner. Res. |
pmid:10646108
|
Tricot G |
New insights into role of microenvironment in multiple myeloma. |
2000 |
Lancet |
pmid:10675068
|
Makhluf HA et al. |
Age-related decline in osteoprotegerin expression by human bone marrow cells cultured in three-dimensional collagen sponges. |
2000 |
Biochem. Biophys. Res. Commun. |
pmid:10679262
|
Merewether LA et al. |
Development of disulfide peptide mapping and determination of disulfide structure of recombinant human osteoprotegerin chimera produced in Escherichia coli. |
2000 |
Arch. Biochem. Biophys. |
pmid:10683254
|
Takayanagi H et al. |
Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. |
2000 |
Arthritis Rheum. |
pmid:10693864
|
Huang L et al. |
Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation. |
2000 |
Am. J. Pathol. |
pmid:10702390
|
Capparelli C et al. |
Osteoprotegerin prevents and reverses hypercalcemia in a murine model of humoral hypercalcemia of malignancy. |
2000 |
Cancer Res. |
pmid:10706080
|
Ross FP |
RANKing the importance of measles virus in Paget's disease. |
2000 |
J. Clin. Invest. |
pmid:10712423
|
Bateman TA et al. |
Osteoprotegerin mitigates tail suspension-induced osteopenia. |
2000 |
Bone |
pmid:10773583
|
Mukohyama H et al. |
The inhibitory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on osteoclast formation are associated with upregulation of osteoprotegerin and downregulation of RANKL and RANK. |
2000 |
Biochem. Biophys. Res. Commun. |
pmid:10777696
|
Atkins GJ et al. |
Expression of osteoclast differentiation signals by stromal elements of giant cell tumors. |
2000 |
J. Bone Miner. Res. |
pmid:10780856
|
Aubin JE and Bonnelye E |
Osteoprotegerin and its ligand: A new paradigm for regulation of osteoclastogenesis and bone resorption. |
2000 |
Medscape Womens Health |
pmid:10792853
|
Thompson SW and Tonge D |
Bone cancer gain without the pain. |
2000 |
Nat. Med. |
pmid:10802700
|
Honore P et al. |
Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. |
2000 |
Nat. Med. |
pmid:10802707
|
Onyia JE et al. |
In vivo demonstration that human parathyroid hormone 1-38 inhibits the expression of osteoprotegerin in bone with the kinetics of an immediate early gene. |
2000 |
J. Bone Miner. Res. |
pmid:10804015
|
Malyankar UM et al. |
Osteoprotegerin is an alpha vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells. |
2000 |
J. Biol. Chem. |
pmid:10811631
|
Kanzawa M et al. |
Involvement of osteoprotegerin/osteoclastogenesis inhibitory factor in the stimulation of osteoclast formation by parathyroid hormone in mouse bone cells. |
2000 |
Eur. J. Endocrinol. |
pmid:10822231
|
Thirunavukkarasu K et al. |
The osteoblast-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function. |
2000 |
J. Biol. Chem. |
pmid:10833509
|
Günther T and Schinke T |
Mouse genetics have uncovered new paradigms in bone biology. |
2000 |
Trends Endocrinol. Metab. |
pmid:10856921
|
Rani CS and MacDougall M |
Dental cells express factors that regulate bone resorption. |
2000 |
Mol. Cell Biol. Res. Commun. |
pmid:10860862
|
Tsurukai T et al. |
Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis. |
2000 |
J. Bone Miner. Metab. |
pmid:10874596
|
Hofbauer LC and Heufelder AE |
Clinical review 114: hot topic. The role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases. |
2000 |
J. Clin. Endocrinol. Metab. |
pmid:10902778
|
Lacey DL et al. |
Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. |
2000 |
Am. J. Pathol. |
pmid:10934148
|
Quinn JM et al. |
Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. |
2000 |
J. Bone Miner. Res. |
pmid:10934644
|
Min H et al. |
Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. |
2000 |
J. Exp. Med. |
pmid:10952716
|
Shiba H et al. |
Effects of ageing on proliferative ability, and the expressions of secreted protein, acidic and rich in cysteine (SPARC) and osteoprotegerin (osteoclastogenesis inhibitory factor) in cultures of human periodontal ligament cells. |
2000 |
Mech. Ageing Dev. |
pmid:10958924
|
López FJ |
New approaches to the treatment of osteoporosis. |
2000 |
Curr Opin Chem Biol |
pmid:10959765
|
Udagawa N et al. |
Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. |
2000 |
Endocrinology |
pmid:10965921
|
Yasuda H |
[A new paradigm of osteoclast biology: discovery of OCIF and ODF]. |
2000 |
Seikagaku |
pmid:10967683
|
Teitelbaum SL |
Bone resorption by osteoclasts. |
2000 |
Science |
pmid:10968780
|
Nakashima T et al. |
Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. |
2000 |
Biochem. Biophys. Res. Commun. |
pmid:10973797
|
Itoh K et al. |
Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors. |
2000 |
J. Bone Miner. Res. |
pmid:10976996
|
Schinke T and Karsenty G |
Vascular calcification--a passive process in need of inhibitors. |
2000 |
Nephrol. Dial. Transplant. |
pmid:10978374
|
Lorenzo J |
Interactions between immune and bone cells: new insights with many remaining questions. |
2000 |
J. Clin. Invest. |
pmid:10995785
|
Teng YT et al. |
Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. |
2000 |
J. Clin. Invest. |
pmid:10995794
|
Børset M et al. |
Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins. |
2000 |
Blood |
pmid:11001907
|
Kobayashi Y et al. |
Force-induced osteoclast apoptosis in vivo is accompanied by elevation in transforming growth factor beta and osteoprotegerin expression. |
2000 |
J. Bone Miner. Res. |
pmid:11028444
|
Zhang YH et al. |
Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. |
2001 |
J. Biol. Chem. |
pmid:11032840
|
Kaneda T et al. |
Endogenous production of TGF-beta is essential for osteoclastogenesis induced by a combination of receptor activator of NF-kappa B ligand and macrophage-colony-stimulating factor. |
2000 |
J. Immunol. |
pmid:11035059
|
Fata JE et al. |
The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. |
2000 |
Cell |
pmid:11051546
|
Miyamoto N et al. |
Spindle-shaped cells derived from giant-cell tumor of bone support differentiation of blood monocytes to osteoclast-like cells. |
2000 |
J. Orthop. Res. |
pmid:11052502
|
Kinpara K et al. |
Osteoclast differentiation factor in human osteosarcoma cell line. |
2000 |
J Immunoassay |
pmid:11071251
|
Kong YY et al. |
Osteoprotegerin ligand: a regulator of immune responses and bone physiology. |
2000 |
Immunol. Today |
pmid:11071528
|
Sakuma Y et al. |
Impaired bone resorption by lipopolysaccharide in vivo in mice deficient in the prostaglandin E receptor EP4 subtype. |
2000 |
Infect. Immun. |
pmid:11083800
|
Riggs BL |
The mechanisms of estrogen regulation of bone resorption. |
2000 |
J. Clin. Invest. |
pmid:11086020
|
Lee ZH et al. |
Activation of c-Jun N-terminal kinase and activator protein 1 by receptor activator of nuclear factor kappaB. |
2000 |
Mol. Pharmacol. |
pmid:11093794
|
Takami M et al. |
Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts. |
2000 |
Endocrinology |
pmid:11108286
|
Gori F et al. |
The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. |
2000 |
Endocrinology |
pmid:11108292
|
Miyamoto T et al. |
An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor kappa B ligand. |
2000 |
Blood |
pmid:11110710
|
|
Proposed standard nomenclature for new tumor necrosis factor members involved in the regulation of bone resorption. The American Society for Bone and Mineral Research President's Committee on Nomenclature. |
2000 |
Bone |
pmid:11113385
|
Takayanagi H et al. |
T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. |
2000 |
Nature |
pmid:11117749
|
Mancini L et al. |
Modulation of the effects of osteoprotegerin (OPG) ligand in a human leukemic cell line by OPG and calcitonin. |
2000 |
Biochem. Biophys. Res. Commun. |
pmid:11118297
|
Kong YY and Penninger JM |
Molecular control of bone remodeling and osteoporosis. |
2000 |
Exp. Gerontol. |
pmid:11121682
|
Shalhoub V et al. |
Characterization of osteoclast precursors in human blood. |
2000 |
Br. J. Haematol. |
pmid:11122091
|
|
Proposed standard nomenclature for new tumor necrosis factor family members involved in the regulation of bone resorption. The American Society for Bone and Mineral Research President's Committee on Nomenclature. |
2000 |
J. Bone Miner. Res. |
pmid:11127193
|
Wan M et al. |
Transcriptional mechanisms of bone morphogenetic protein-induced osteoprotegrin gene expression. |
2001 |
J. Biol. Chem. |
pmid:11139569
|
Browner WS et al. |
Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. |
2001 |
J. Clin. Endocrinol. Metab. |
pmid:11158021
|
Yun TJ et al. |
Osteoprotegerin, a crucial regulator of bone metabolism, also regulates B cell development and function. |
2001 |
J. Immunol. |
pmid:11160187
|
Hofbauer LC et al. |
Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells. |
2001 |
Biochem. Biophys. Res. Commun. |
pmid:11162519
|
Brändström H et al. |
Regulation of osteoprotegerin secretion from primary cultures of human bone marrow stromal cells. |
2001 |
Biochem. Biophys. Res. Commun. |
pmid:11162596
|
Wuyts W et al. |
Evaluation of the role of RANK and OPG genes in Paget's disease of bone. |
2001 |
Bone |
pmid:11165949
|
Takemura M et al. |
Relationship between osteoprotegerin/osteoclastogenesis inhibitory factor concentration in synovial fluid and disease severity in individuals with osteoarthritis of the knee. |
2001 |
Metab. Clin. Exp. |
pmid:11172466
|
Gravallese EM et al. |
The role of TNF-receptor family members and other TRAF-dependent receptors in bone resorption. |
2001 |
Arthritis Res. |
pmid:11178122
|
Makiishi-Shimobayashi C et al. |
Interleukin-18 up-regulates osteoprotegerin expression in stromal/osteoblastic cells. |
2001 |
Biochem. Biophys. Res. Commun. |
pmid:11181055
|
O'Brien EA et al. |
Osteoprotegerin is produced when prostaglandin synthesis is inhibited causing osteoclasts to detach from the surface of mouse parietal bone and attach to the endocranial membrane. |
2001 |
Bone |
pmid:11182380
|
Bénard J |
[From metastatic osteolysis a painful message: beginning to understand with osteoprotegerin? |
2000 |
Bull Cancer |
pmid:11184451
|
Clohisy DR et al. |
Osteoprotegerin inhibits tumor-induced osteoclastogenesis and bone tumor growth in osteopetrotic mice. |
2000 |
J. Orthop. Res. |
pmid:11192258
|
Aubin JE and Bonnelye E |
Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption. |
2000 |
Osteoporos Int |
pmid:11193242
|
Wise GE et al. |
Osteoprotegerin and osteoclast differentiation factor in tooth eruption. |
2000 |
J. Dent. Res. |
pmid:11201042
|
Bekker PJ et al. |
The effect of a single dose of osteoprotegerin in postmenopausal women. |
2001 |
J. Bone Miner. Res. |
pmid:11204435
|
Kikuchi T et al. |
Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. |
2001 |
J. Immunol. |
pmid:11207318
|
Kotake S et al. |
[Molecular mechanism of bone metabolism]. |
2000 |
Nippon Naika Gakkai Zasshi |
pmid:11215116
|